Zoetis planning to offer senior notes in two maturities

By Aleesia Forni

Virginia Beach, Nov. 9 – Zoetis Inc. is in Monday’s market with an offering of senior notes in two tranches, according to a 424B3 filing with the Securities and Exchange Commission.

The notes feature a change-of-control put at 101%.

BofA Merrill Lynch, Barclays, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are the bookrunners.

Proceeds will be used to repay amounts drawn under a revolving credit facility to fund the $765 million purchase price of Salar Topco AS, to repay $400 million of 1.15% senior notes due 2016 and for general corporate purposes.

Zoetis is an animal health subsidiary of Pfizer Inc., based in New York City.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.